Example: quiz answers

Media contacts - janssen.com

MUNICH, August 27, 2018 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the results of the Phase 3 MARINER and COMMANDER HF (heart failure) studies, which were presented this week at the European Society of Cardiology (ESC) Congress 2018 and simultaneously published in The New England Journal of Medicine.

Tags:

  European, Society, 2018, Congress, Cardiology, European society of cardiology, Munich, Congress 2018

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Related search queries